Med. praxi. 2011;8(5):219-221

Pharmacology of sleep disorders in clinical practice

doc.MUDr.Petr Smolík, CSc.
Centrum pro poruchy spánku a biorytmů, Psychiatrická klinika, Fakultní nemocnice v Hradci Králové

Prevalence of insomnias and other sleep disorders has been growing up in the course of past years (1). Pharmacology of sleep disorders

has always been a complex process that includes behavioral, neurophysiologic, psychological, chronobiological and, not in the least,

pharmacological factors. Negative influence of different pharmaceuticals use to be very often neglected or underrated. In reverse, an

extent of positive treatment possibilities of pharmacotherapy has been perceived inconsistently very often at present. The simple classification

of pharmaceuticals for insomnia into sedatives/hypnotics and stimulants respectively, can’t stand up in the context of nowadays

knowledge about neurophysiology and chronobiology of sleep process.

Keywords: sleep disorders, sleeplessness, insomnia, hypnotics, chronohypnotics, chronobiotics, sedatives, chronobiology, drug interactions

Published: June 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Smolík P. Pharmacology of sleep disorders in clinical practice. Med. praxi. 2011;8(5):219-221.
Download citation

References

  1. Zammit GK. The prevalence, morbidities, and treatments of insomnia. CNS Neurol Disord Drug Targets 2007; 6: 3-16. Go to original source... Go to PubMed...
  2. Smolík P. Chronobiologické komponenty duševních poruch. Psychiatr. prax. 2008; 9: 117-120.
  3. Nevšímalová S, Šonka K, a kol. Poruchy spánku a bdění. Praha: Galén, 2005: 345 s.
  4. Švestka J. Nová psychofarmaka: Melatonin s prodlouženým účinkem v léčbě primární insomnie u starších osob. Psychiatrie 2008; 12: 160-166.
  5. Švestka J. Agomelatin - nové melatonergní a serotonergní antidepresivum. Psychiatrie 2005; 9: 307-310.
  6. Lange K, Geisler P, Klein HE, Hajak G. Sedative antidepressants in the treatment of primary insomnia. Psychiatr Prax. 2007; 34(Suppl 1): 95-97. Go to original source...
  7. Ziegler G, Ploch M, Miettinen-Baumann A, Doplet W. Efficacy and tolerability of valerian extrakt LI 156 compared with oxazepam in the treatment of non-organic insomnia - a randomized, double-blind, komparative clinical study. Eur J med Res 2002; 7: 480-486.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.